David A. Siegel Ampio Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.08 - $21.0 $26,024 - $6.83 Million	325,300 Added 304.26%	432,216 $26,000
Q2 2022 Aug 15, 2022	BUY	$0.16 - $0.47 $17,106 - $50,250	106,916 New	106,916 $18,000
Q3 2019 Nov 14, 2019	SELL	$0.38 - $0.52 $34,618 - $47,372	-91,100 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$0.39 - $0.7 $1,638 - $2,940	-4,200 Reduced 4.41%	91,100 $35,000
Q1 2019 May 15, 2019	BUY	$0.43 - $0.68 $86 - $136	200 Added 0.21%	95,300 $54,000
Q4 2018 Feb 14, 2019	BUY	$0.39 - $0.7 $3,744 - $6,720	9,600 Added 11.23%	95,100 $38,000
Q3 2018 Nov 14, 2018	BUY	$0.44 - $3.02 $308 - $2,114	700 Added 0.83%	85,500 $43,000
Q2 2018 Aug 14, 2018	BUY	$1.66 - $3.82 $69,720 - $160,440	42,000 Added 98.13%	84,800 $187,000
Q1 2018 May 15, 2018	BUY	$2.16 - $3.48 $92,448 - $148,944	42,800 New	42,800 $146,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.